Maresca P, Mancinelli R, Corsico N, Arrigoni-Martelli E, Manni E
Dipartimento di Farmacologia, Sigma-Tau S.p.A., Rome, Italy.
Eur J Pharmacol. 1995 Dec 20;287(3):303-7. doi: 10.1016/0014-2999(95)00699-0.
Propionyl-L-carnitine has been shown to exert a beneficial effect on cardiac function in different experimental models of cardiomyopathy in the rat, most likely by improving cardiac metabolism and energy production. We have previously shown that, in a strain of hamsters with hereditary dilated cardiomyopathy (BIO TO.2), the mechanical activity of papillary muscle (length-tension, velocity of shortening, shortening, work and power relationship) is significantly depressed when compared to the same parameter in normal hamsters (BIO F1.B). The repeated oral treatment with propionyl-L-carnitine (60 mg/kg per os for 7 weeks) to BIO TO.2 hamsters had a significant positive inotropic effect, as indicated by an increase in developed tension up to the levels observed in papillary muscles from normal hamsters. This action is most likely associated with metabolic effects similar to those observed in rats.
已证明,在大鼠心肌病的不同实验模型中,丙酰-L-肉碱对心脏功能具有有益作用,这很可能是通过改善心脏代谢和能量产生来实现的。我们之前已经表明,在患有遗传性扩张型心肌病的仓鼠品系(BIO TO.2)中,与正常仓鼠(BIO F1.B)的相同参数相比,乳头肌的机械活动(长度-张力、缩短速度、缩短、功和功率关系)显著降低。对BIO TO.2仓鼠进行丙酰-L-肉碱重复口服治疗(60毫克/千克口服,持续7周)具有显著的正性肌力作用,表现为舒张期张力增加,直至达到正常仓鼠乳头肌中观察到的水平。这种作用很可能与在大鼠中观察到的类似代谢效应有关。